Novartis has announced that the U.S. Food and Drug Administration (FDA) approved Lutathera for the treatment of gastroenteropancreatic neuroendocrine tumors...
therapy
Published: 28 November 2023A treatment for Wolman disease is now available in England following clinical trials at NIHR Manchester Clinical...
